表現データベース
-
ADMA level - lipophilic, hydrophilic
Additionally, ADMA levels in the lipophilic group were significantly lower than those in the non-statin and hydrophilic groups.
-
Amelioration
Drug A (3 mg/kg/day) clearly ameliorated this periostitis and bone destruction (Fig. 5C), whereas Drug B induced no obvious effect (Fig. 5D).
-
Ang II
This result conclusively shows that, on bone marrow-derived cells, the receptor is not required for peripheral blood erythrocytosis to be induced by Ang II.
These bone marrow transplantation results implied that the erythrocytosis induced by Ang II is due mainly to the stimulation of AT1aR present in the recipient organs, such as on kidney or liver cells.
First, we determined which Ang II receptor subtypes are expressed by the spleen and bone marrow cells of wild-type (WT) mice.
-
Binding motifs - transcription factor
Several binding motifs for potent transcription factor NF-IL6 were located adjacent to each NF-κB site
-
Bone disorganization - radiography
As shown in Figs. 5 and 6, radiography of the hind limb from the vehicle-treated group showed severe disorganization (periostitis and destruction) of bone in the distal tibia, tarsus, metatarsus and calcaneus (Fig. 5B).
-
bone marrow cells
Recipient female mice aged 8 or 9 weeks were lethally irradiated and divided into two groups. One group received bone marrow cells from male donor WT mice (designated as X<-WT), and the second received cells from male donor angiotensin II type 1a receptor-deficient mice (AT1-KO) (designated as X<-AT1-KO). As a control, irradiated female WT mice also received bone marrow cells from male donor WT mice (designated as X<-WT).
-
bone marrow transplant
To evaluate how end-organ damage is affected by AT1 activity in BMDCs, we conducted bone marrow transplantation (BMT) experiments as described previously (31).
These bone marrow transplantation results implied that the erythrocytosis induced by Ang II is mainly due to the stimulation of AT1aR present in the recipient organs, such as on kidney or liver cells.
-
Cervical lymph node metastases - olfactory neuroblastoma
Of the 12 patients with olfactory neuroblastoma, five experienced recurrent episodes of the disease, three had intracranial invasion, one had cervical lymph node metastases, one had distant metastases, and two were considered to be in Kadish stage B.
-
Chemotherapy - toxicity
Chemotherapy-related toxicity was graded according to the National Cancer Institute Common Toxicity Criteria version 2. The most common grade 3 or 4 toxicities were leucopenia (33%), neutropenia (50%), febrile neutropenia (8%) and diarrhea (25%), all of which were manageable.
-
Death - due to treatment
None of the seven patients died as a result of treatment, nor did they suffer any severe toxic side effects due to irradiation, such as vision impairment, brain necrosis, etc. This lack of side effects notwithstanding, ongoing follow-up must be performed.
-
Follow-up period
The median follow-up period for survivors was 22.2 months (range: 14.8 - 63 months).
-
Frequency - decreased
Drug A (1 mg/kg/day) and Drug B (3 mg/kg/day) significantly decreased the frequency of incidence compared with the vehicle-treated group (Fig. 2)
-
Gene sequence deletion - NF-κB
Further deletion between -208 and -188 (Δ-208Luc and Δ-188/Luc), which resulted in the loss of the tandem repetition of NF-κB sequences at the pκB1 site, entirely abolished both basal activity and lipopolysaccharide inducibility.
-
Groups - drug-treated
No differences between the vehicle-treated and drug-treated groups were seen.
-
Histological evaluation
During histopathological evaluation, none of the animals exhibited catastrophic degradation in any group. In the vehicle-treated group, relatively severe injuries, such as fibrin deposition and infiltration of neutrophils was seen in the synovium (data not shown).
-
IL-6 and IFN-γ - activation of NF-IL6, STAT3, and STAT1
IL-6 and IFN-γ, which activate NF-IL6, STAT3, and STAT1 [34, 35], were unable to increase hBD-2 promoter activity in RAW 264.7 cells transfected with the hBD2/Luc plasmid.
-
In vitro assay
In contrast, compound X dose-dependently inhibited both recombinant human COX-1 and COX-2 in all three in vitro assays.
-
Inclusion criteria
Animals with lymphoid tissue lesions failed to meet the inclusion criteria and were excluded from the count.
-
Increased frequency
Vocalization frequency increased significantly in the vehicle-treated AIA group compared with the normal group.
-
Infection - age strata
In the hospital in question, infection was frequent in the 40-49 age strata (p = 0.015).
-
Inhibition
In the PGE2 ELISA and peroxidase assay, compound X hardly inhibited COX-1 and COX-2 at all.
Since platelets do not express COX-2, TXB2 production from whole blood platelets was used as a measure of COX-1 inhibitory activity.
-
Inhibition - dose-dependent
Compound X inhibited PGE2 dose-dependently in the exudates.
Compound X inhibited carrageenan-induced edema in a dose-dependent manner.
In contrast, compound X dose-dependently inhibited both recombinant human COX-1 and COX-2 in all three in vitro assays.
-
Macrophage-like cell line - RAW 264.7 - transient transfection
These constructs were then transiently transfected into the RAW 264.7 macrophage-like cell line.
-
Metastatic disease
The median survival period for the 6 out of 12 patients with recurrent or distant metastatic disease was 16.1 months (Figure 3).
-
Optimal treatment - cancer patients
Together, these reports suggest that the optimal treatment for surgically resectable cases is surgery followed by adjuvant radiation therapy.
-
Outbreak - rate of spread
If an outbreak was simply allowed to continue spreading under these conditions, the results showed that approximately 50 to 90 symptomatic cases would occur by Day 30.
-
Patient age
The median age of patients was 39 years (range: 17-63 years).
The treatment response rate was 75% (3/4) in the group aged less than 50 years, but 0% (0/8) in those over 50 (P = 0.018).
-
Patient characteristics
The characteristics of the 43 patients (29 males and 14 females) included in the study are summarized in Table I.
-
Paw volume
Drug A and Drug B decreased paw volume in a dose-dependent manner in rats.
-
Phylogenetic tree
A phylogenetic tree was constructed by the NJ method to investigate genetic relationships among the 20 partial sequences of 16S rRNA gene (with 12 kinds of sequence) obtained in this study and the 57 sequences of organism RNA in the database (Fig. 1).
-
Promotor activity - synergistic effects
Lipopolysaccharide with IFN-γ or IL-6 exerted no synergistic effects on hBD-2 promoter activity (data not shown).
-
Radiation therapy - definitive
Of the five CR patients who received definitive radiation therapy (one by photon radiation and four by proton radiation), four are alive with no evidence of disease at the time of writing.
-
Radiation therapy - proton, photon
Of the 7 of 12 patients with locoregional disease who had received no prior radiation therapy, one received the treatment followed by photon radiation and the remaining six received the treatment followed by proton radiation.
The toxicity of definitive photon or proton radiation therapy was mild and manageable.
-
RAS activation
Our results suggest that RAS activation induces overproduction of Epo via AT1 receptor in vivo.
-
Receptor subtype determina-tion - Ang II
First, we determined which Ang II receptor subtypes are expressed by the spleen and bone marrow cells of wild-type (WT) mice.
-
Recommended dose
In a previous phase I study at our institution, the recommended dose for this regimen was determined to be 50 mg/m2 for Drug A and 30 mg/m2 for Drug B (25).
-
Relationship
The relationship between the predictor candidates and CD34+ numbers was evaluated.
-
Response rate - age groups
The treatment response rate was 75% (3/4) in the group aged less than 50 years, but 0% (0/8) in those over 50 (P = 0.018).
-
Results - by culture
Five Legionella isolates were detected in four samples from three buildings (two hotels and one office) by culture.
-
Salt bridge
The carboxylate of compound X was shown to form a salt bridge with compound Y.
-
Selectivity
The COX-2 selectivity of compound X, namely the COX-1 IC50/COX-2 IC50 ratio, was 0.14-0.35 (Table 1).
-
Sequence deletion - dκB
Deletion of the dκB sequence (Δ-2187/Luc) did not alter this activity in response to lipopolysaccharide.
-
Serum ADMA concentration - statin
Serum ADMA concentrations were significantly lower in the statin than non-statin group (P=0.007).
-
Stochastic effects - infection
When the stochastic effects are taken into account, together with the effects of single precautionary measures and isolation, the rapid implementation of combined measures reduces the rate of transmission and increases the probability of extinction.
-
Survival period
The median overall survival period was 36.6 months (Figure 2).
The median survival period for the 6 out of 12 patients with recurrent or distant metastatic disease was 16.1 months (Figure 3).
-
Survival rates
The 1- and 2-year survival rates were estimated to be 83.3% and 53.3%, respectively.
Among these, the 2-year survival rate was 100%, and six were still alive at the time this report was written (Figure 4).
-
Tendency to increase
As shown in Table 2, the vehicle-treated group showed a tendency to increase gastric lesions compared with normal rats.
-
Toxicity - radiation therapy - photon, proton
The toxicity of definitive photon or proton radiation therapy was mild and manageable.
-
Transcriptional activity - hBD-2 gene - mononuclear phagocytes
Confers both the basal and LPS-induced transcriptional activity of the hBD-2 gene in mononuclear phagocytes.
-
TXB2 production
Since platelets do not express COX-2, TXB2 production from whole blood platelets was used as a measure of COX-1 inhibitory activity.
-
Vehicle-treated
Mild cartilage destruction was seen in the vehicle-treated rats, but neither Drug A nor Drug B had any effect on this change at any dose (Fig. 7, 8B).
No differences between the vehicle-treated and drug-treated groups were seen.




